U.S. INTRAVENOUS SOLUTIONS MARKET ANALYSIS

U.S. Intravenous Solutions Market, By Solution Type (Saline(Normal Saline (0.9% NaCl), Hypertonic Solution), Dextran (D5W 5% dextrose in water, Analog Hypertonic Saline), Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and trace elements, Mixed Solutions), By Packaging (Ampules, Vials, Cartridges, Bottles, Bags (Large Volume Bags (greater than 250ml), Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, Irrigation IV Solution), By End User (Hospital, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others)

Restraints & Challenges:

U.S Intravenous Solutions Market – Drivers

Increasing launches and regulatory approvals for intravenous solution injection: Market players are involved in launching new intravenous injection solutions, which is expected to boost the growth of the U.S. intravenous solutions market over the forecast period.
Increasing prevalence of chronic respiratory diseases: The increasing prevalence of chronic respiratory diseases is expected to increase the demand for intravenous solutions, thereby driving the U.S intravenous solutions market’s growth.

Growth Drivers: